SG11201603091QA - Ferric citrate for reducing cardiac failure in chronic kidney disease patients - Google Patents
Ferric citrate for reducing cardiac failure in chronic kidney disease patientsInfo
- Publication number
- SG11201603091QA SG11201603091QA SG11201603091QA SG11201603091QA SG11201603091QA SG 11201603091Q A SG11201603091Q A SG 11201603091QA SG 11201603091Q A SG11201603091Q A SG 11201603091QA SG 11201603091Q A SG11201603091Q A SG 11201603091QA SG 11201603091Q A SG11201603091Q A SG 11201603091QA
- Authority
- SG
- Singapore
- Prior art keywords
- kidney disease
- chronic kidney
- disease patients
- ferric citrate
- cardiac failure
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Inorganic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361899866P | 2013-11-04 | 2013-11-04 | |
| PCT/US2014/063643 WO2015066593A1 (en) | 2013-11-04 | 2014-11-03 | Ferric citrate for reducing cardiac failure in chronic kidney disease patients |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201603091QA true SG11201603091QA (en) | 2016-05-30 |
Family
ID=53005244
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201603091QA SG11201603091QA (en) | 2013-11-04 | 2014-11-03 | Ferric citrate for reducing cardiac failure in chronic kidney disease patients |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US20160256486A1 (zh) |
| EP (2) | EP3747432A1 (zh) |
| JP (3) | JP2016535780A (zh) |
| KR (1) | KR102392441B1 (zh) |
| CN (1) | CN105873583A (zh) |
| AU (1) | AU2014341975A1 (zh) |
| BR (1) | BR112016009901A8 (zh) |
| CA (1) | CA2928200A1 (zh) |
| EA (1) | EA201690926A1 (zh) |
| HK (1) | HK1223031A1 (zh) |
| IL (1) | IL245317A0 (zh) |
| MX (1) | MX2016005734A (zh) |
| SG (1) | SG11201603091QA (zh) |
| TW (2) | TWI744215B (zh) |
| WO (1) | WO2015066593A1 (zh) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102573807A (zh) | 2009-07-21 | 2012-07-11 | 凯克斯生物制药公司 | 柠檬酸铁剂型 |
| LT3003327T (lt) | 2013-06-05 | 2017-12-27 | Tricida Inc. | Protonus surišantys polimerai, skirti geriamajam vartojimui |
| EP3157516A4 (en) | 2014-06-22 | 2017-12-13 | Dexcel Pharma Technologies Ltd. | Pharmaceutical compositions comprising ferric citrate and methods for the production thereof |
| ES2857177T3 (es) | 2014-12-10 | 2021-09-28 | Tricida Inc | Polímeros de unión de protones para administración oral |
| US20190209607A1 (en) | 2016-05-06 | 2019-07-11 | Tricida, Inc. | Compositions for treating acid-base disorders |
| US11266684B2 (en) | 2017-11-03 | 2022-03-08 | Tricida, Inc. | Compositions for and method of treating acid-base disorders |
| JP2022505697A (ja) | 2018-10-29 | 2022-01-14 | ファーマコスモス ホールディング エー／エス | カルボキシマルトース第二鉄による鉄欠乏症の治療 |
| CN114286682A (zh) * | 2019-02-09 | 2022-04-05 | 法码科思莫斯控股有限公司 | 治疗具有心血管不良事件风险的个体的铁缺乏以及用于治疗心房颤动的铁 |
| EP4347022A1 (en) * | 2021-05-27 | 2024-04-10 | Keryx Biopharmaceuticals, Inc. | Pediatric formulations of ferric citrate |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE351366B (zh) * | 1965-06-08 | 1972-11-27 | Teikoku Hormone Mfg Co Ltd | |
| US20050203169A1 (en) * | 2001-08-06 | 2005-09-15 | Moskowitz David W. | Methods and compositions for treating diseases associated with excesses in ACE |
| TWI335218B (en) | 2003-02-19 | 2011-01-01 | Panion & Bf Biotech Inc | Ferric organic compounds, uses thereof and methods of making same |
| US8093423B2 (en) | 2003-02-19 | 2012-01-10 | Globoasia, Llc | Pharmaceutical-grade ferric organic compounds, uses thereof and method of making same |
| MX2008002360A (es) * | 2005-08-18 | 2008-04-29 | Globoasia Llc | Compuestos organicos ferricos grado farmaceutico, uso de los mismos y metodos para elaborar los mismos. |
| WO2007089571A2 (en) * | 2006-01-30 | 2007-08-09 | Globoasia, Llc | Method of treating chronic kidney disease |
| KR20080094013A (ko) * | 2006-01-30 | 2008-10-22 | 글로보아시아 엘엘씨 | 연조직의 석회화 역전, 예방, 지연 또는 안정화 방법 |
| CN102573807A (zh) * | 2009-07-21 | 2012-07-11 | 凯克斯生物制药公司 | 柠檬酸铁剂型 |
| JP5827326B2 (ja) * | 2010-07-07 | 2015-12-02 | アーデリクス，インコーポレーテッド | リン酸輸送を阻害する化合物及び方法 |
| KR102150135B1 (ko) * | 2012-06-21 | 2020-08-31 | 케릭스 바이오파마슈티컬스 인코포레이티드 | 만성 신장 질환 환자의 치료에서 시트르산 제2철의 용도 |
-
2014
- 2014-11-03 EP EP20173867.1A patent/EP3747432A1/en active Pending
- 2014-11-03 SG SG11201603091QA patent/SG11201603091QA/en unknown
- 2014-11-03 KR KR1020167014000A patent/KR102392441B1/ko active IP Right Grant
- 2014-11-03 CA CA2928200A patent/CA2928200A1/en not_active Abandoned
- 2014-11-03 EA EA201690926A patent/EA201690926A1/ru unknown
- 2014-11-03 AU AU2014341975A patent/AU2014341975A1/en not_active Abandoned
- 2014-11-03 BR BR112016009901A patent/BR112016009901A8/pt not_active Application Discontinuation
- 2014-11-03 CN CN201480072217.1A patent/CN105873583A/zh active Pending
- 2014-11-03 EP EP14858106.9A patent/EP3065734A4/en not_active Ceased
- 2014-11-03 US US15/031,678 patent/US20160256486A1/en not_active Abandoned
- 2014-11-03 JP JP2016552432A patent/JP2016535780A/ja active Pending
- 2014-11-03 WO PCT/US2014/063643 patent/WO2015066593A1/en active Application Filing
- 2014-11-04 TW TW103138244A patent/TWI744215B/zh active
- 2014-11-04 TW TW110136784A patent/TW202203910A/zh unknown
-
2015
- 2015-01-29 MX MX2016005734A patent/MX2016005734A/es unknown
-
2016
- 2016-04-27 IL IL245317A patent/IL245317A0/en unknown
- 2016-09-27 HK HK16111332.6A patent/HK1223031A1/zh unknown
-
2018
- 2018-12-11 US US16/216,772 patent/US20190307791A1/en not_active Abandoned
-
2019
- 2019-07-31 JP JP2019140640A patent/JP6828100B2/ja active Active
-
2021
- 2021-01-20 JP JP2021007091A patent/JP2021073230A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP3065734A1 (en) | 2016-09-14 |
| CA2928200A1 (en) | 2015-05-07 |
| MX2016005734A (es) | 2016-11-08 |
| JP2019206562A (ja) | 2019-12-05 |
| EP3065734A4 (en) | 2017-05-17 |
| US20190307791A1 (en) | 2019-10-10 |
| TW201609088A (zh) | 2016-03-16 |
| AU2014341975A1 (en) | 2016-05-19 |
| CN105873583A (zh) | 2016-08-17 |
| KR102392441B1 (ko) | 2022-05-02 |
| JP2021073230A (ja) | 2021-05-13 |
| TW202203910A (zh) | 2022-02-01 |
| BR112016009901A8 (pt) | 2020-04-14 |
| HK1223031A1 (zh) | 2017-07-21 |
| JP2016535780A (ja) | 2016-11-17 |
| EP3747432A1 (en) | 2020-12-09 |
| IL245317A0 (en) | 2016-06-30 |
| JP6828100B2 (ja) | 2021-02-10 |
| EA201690926A1 (ru) | 2016-09-30 |
| US20160256486A1 (en) | 2016-09-08 |
| TWI744215B (zh) | 2021-11-01 |
| KR20160096597A (ko) | 2016-08-16 |
| WO2015066593A1 (en) | 2015-05-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1223031A1 (zh) | 用於降低慢性腎病患者的心力衰竭的枸櫞酸鐵 | |
| HK1214503A1 (zh) | 檸檬酸鐵在治療慢性腎臟疾病患者中的應用 | |
| IL285843A (en) | Ibrutinib for use in the treatment of graft-versus-host disease | |
| HK1218402A1 (zh) | 用於進行交替和順序的血液和腹膜透析方式的系統及方法 | |
| IL242804B (en) | Pridopidine for use in reducing impairment of functional capacity in huntington disease patients | |
| EP3862044C0 (en) | TWO-TIP HEMODIALYSIS CATHETER | |
| EP2950874A4 (en) | OCCLUSION OF A BODY LIGHT | |
| EP2925382A4 (en) | AMBULATORY AND EXTRACORPORAL ASSISTANCE PUNGON | |
| EP2968048A4 (en) | PATIENT SIDE SURGICAL CARRIER HAVING DIRECTION INTERFACE | |
| EP2833957A4 (en) | THERAPY FOR CHILDREN'S DISEASE AND / OR HEART FAILURE THROUGH INTRADERMAL INFUSION | |
| HK1214526A1 (zh) | 眼底疾病治療劑 | |
| HK1220898A1 (zh) | 包含 鍵的衍生物在患有腎功能衰竭的患者中的用途 | |
| CL2016000447A1 (es) | Marcadores de riesgo para cardiovasculopatías en pacientes con nefropatía crónica. | |
| HK1225443A1 (zh) | 在心力衰竭中用於抑制素治療分層的標記物 | |
| IL240218B (en) | Catheter for blockage between a nerve and an organ | |
| EP2959905A4 (en) | ORAL ADMINISTRATIVE ADSORBENT, THERAPEUTIC AGENT AGAINST CHILDING DISEASE AND THERAPEUTIC AGENT AGAINST LIVER DISEASES | |
| EP2959908A4 (en) | ORAL ADMINISTRATIVE ADSORBENT, THERAPEUTIC AGENT AGAINST CHILDING DISEASE AND THERAPEUTIC AGENT AGAINST LIVER DISEASES | |
| EP2959906A4 (en) | ADSORBENT FOR ORAL ADMINISTRATION, MEDICAMENT FOR RENAL DISEASE, AND MEDICAMENT FOR LIVER DISEASE | |
| PL2875049T3 (pl) | Sposoby zapobiegania i leczenia przewlekłej choroby nerek (ckd) | |
| GB201305758D0 (en) | Blood Pump | |
| HK1220622A1 (zh) | 的生理性配體 | |
| EP3217987A4 (en) | Sglt-2 inhibitors for treating metabolic disorders in patients with renal impairment or chronic kidney disease | |
| EP2959907A4 (en) | ADSORBENT FOR ORAL ADMINISTRATION, MEDICAMENT FOR RENAL DISEASE, AND MEDICAMENT FOR LIVER DISEASE | |
| RS57172B1 (sr) | Preparati za upotrebu u lečenju dislipidemije kod hroničnog oboljenja bubrega | |
| PT2849835T (pt) | Cateter venoso central não temporário para utilização em hemodiálise |